Back
Apellis Pharmaceuticals Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
42
APLS
Apellis Pharmaceuticals
Last Price:
29.07
Seasonality Move:
22.1%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.62 | Buy |
| 20-day SMA: | 27.47 | Buy |
| 50-day SMA: | 31.83 | Sell |
| 200-day SMA: | 44.76 | Sell |
| 8-day EMA: | 27.81 | Buy |
| 20-day EMA: | 28.14 | Sell |
| 50-day EMA: | 30.87 | Sell |
| 200-day EMA: | 40.98 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.87 | Sell |
| Relative Strength Index (14 RSI): | 45.96 | Sell |
| Chaikin Money Flow: | 8609149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.04 - 28.04) | Buy |
| Bollinger Bands (100): | (30.03 - 39.99) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 28.08 while APLS 8-day simple moving average is 27.62, which is a Buy signal.
- The stock price of APLS is 28.08 while Apellis Pharmaceuticals 20-day SMA is 27.47, which makes it a Buy.
- Apellis Pharmaceuticals 50-day simple moving average is 31.83 while APLS share price is 28.08, making it a Sell technically.
- APLS stock price is 28.08 and Apellis Pharmaceuticals 200-day simple moving average is 44.76, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $28.08. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
3.42B
Price in USD:
28.08
Share Volume:
9.86M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
24.34
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 28.08 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 28.08 while APLS 8-day exponential moving average is 27.81, which is a Buy signal.
- The stock price of APLS is 28.08 while Apellis Pharmaceuticals 20-day EMA is 28.14, which makes it a Sell.
- Apellis Pharmaceuticals 50-day exponential moving average is 30.87 while APLS share price is 28.08, making it a Sell technically.
- APLS stock price is 28.08 and Apellis Pharmaceuticals 200-day simple moving average is 40.98, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and an increase next year of $1.33 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -0.87, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 45.96, which suggest Apellis Pharmaceuticals is oversold
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (27.04 - 28.04), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (30.03 - 39.99), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.